News and Updates

Geron Could Resume Stem Cell Trial

Geron stated that subsequent to their recent discussions with the FDA, they believe they will have sufficient new animal data to allow for continuation of the trial sometime in thei third quarter of 2010.

Read More »

Stem cell therapy maker Aldagen files for IPO

The adult stem cell company Aldagen Inc, from Durham North Carolina announced today that it has filed a registration with the Securities Exchange Commission for an initial public offering with a potential value of $80.5 million.

Read More »

Take the first step towards the healthier life you deserve.

The Stem Cell Institute has integrated Intranasal MTF Therapy into its autism protocol:

  • MTF therapy features exosomes and over 300 beneficial molecules
  • Works in synergy with our stem cells
  • Offers anti-inflammatory and regenerative effects
  • Delivered in an easy-to-administer aerosol format via the nose
  • To discover more about MTF and its benefits, click here